Navigation Links
VWR International, LLC Expands European Portfolio With Acquisitions Of Labonord SAS And Switch BVBA
Date:12/4/2012

RADNOR, Pa., Dec. 4, 2012 /PRNewswire/ -- VWR International, LLC, a leading global laboratory supply and distribution company, announced today that it has acquired Labonord SAS and Switch BVBA, expanding the company's cytology and histology portfolio in Europe.

(Logo: http://photos.prnewswire.com/prnh/20101109/NY97837LOGO )

Based in Lille, France, Labonord is an independent supplier of consumables and chemicals and also represents a number of leading suppliers of histology products in France. Belgium-based Switch, a manufacturer of cytology and histology reagents and dyes, produces products under the Q-Path brand which are distributed through Labonord and an independent distribution partner and sold to customers in France, Belgium and the Netherlands.

"Labonord and Switch are recognized nationally throughout France and Belgium as trusted brands in the histology and cytology field," stated Manuel Brocke-Benz, CEO, Senior Vice President and Managing Director of European Operations. "This acquisition will enable VWR to expand its histology and cytology portfolio in these regions and provide opportunities to offer the Q-Path product across Europe. We welcome the Labonord and Switch teams to the VWR organization."

Financial details of this acquisition remain confidential.

About VWR International, LLC

VWR International, LLC, headquartered in Radnor, Pennsylvania, is a global laboratory supply and distribution company with worldwide sales in excess of $4.1 billion in 2011. VWR enables the advancement of the world's most critical research through the distribution of a highly diversified product line to most of the world's top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. With over 150 years of industry experience, VWR offers a well-established distribution network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 8,000 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services.

For more information on VWR, phone 1-800-932-5000, visit www.vwr.com, or write, VWR, Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, PA 19087.

VWR and design are registered trademarks of VWR International, LLC.


'/>"/>
SOURCE VWR International, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
3. Chindex International, Inc. to Report First Quarter 2012 Financial Results
4. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
5. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
6. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
7. SurgLine International, Inc. to Expand its Trauma Product Line With Completion of Acquisition
8. DATATRAK International, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
9. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. BioMed Diagnostics Microbiology Diagnostic Devices Now Available Worldwide Through Distribution Agreement With VWR International, LLC
11. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Januar 2017  ResMed (NYSE: RMD ), ... Medical ( Winter Haven, Florida ) gaben ... die Beilegung aller globalen Rechtsstreitigkeiten zwischen den Parteien geeinigt ... ihrer bestehenden Produkte im Tausch gegen Lizenzgebühren an ResMed ... leisten, um das in Florida ...
(Date:1/22/2017)... DAVOS, Switzerland and ABU DHABI , ... leaders from the US ... , Hospital of the Future , at ... in the hospital of the future will be driven by big data and ... better," according to the panel of experts that discussed the ,Hospital of the ...
(Date:1/21/2017)... Mass. , Jan. 20, 2017 /PRNewswire/ ... Keystone Symposia Conference, "PI3K Pathways in Immunology, ... Inc. (NASDAQ: INFI ) ... immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase-gamma ... able to help overcome resistance to checkpoint ...
Breaking Medicine Technology:
(Date:1/22/2017)... ... ... Zifam Pinnacle, an Australian company dedicated to providing a unique range of ... the January ECRM Trade Show in Hilton Head, SC. , Zifam Pinnacle develops products ... of its creations to help create a more traditional and natural approach to healthy ...
(Date:1/21/2017)... ... 2017 , ... Caronlab Australia, an Australian company known for health and beauty ... Head, SC, where it benefited from outstanding meetings with major retail buyers. , Caron ... products. At this trade show, the company had the chance to demonstrate its products ...
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats ... of its owner and founder. As Oat is recognized globally as one of the ... personally as he believes it is a move to sow the seed of good ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... Redwood Family Dermatology has recently joined their multi-specialty medical group. The ... range of cosmetic services. , “We’re excited to add this excellent dermatology practice ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Periodontist Dr. Dan Holtzclaw in media for its creos™ line of bone regenerative ... by Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a ...
Breaking Medicine News(10 mins):